Biofrontera Announces Mediation Results
November 19, 9:49 AM
Biofrontera AG (NASDAQ:BFRA, Frankfurt Stock Exchange: B8F)))) (OTC:BFFTF) has been in mediation proceedings with Mr. Wilhelm K. T. Zours and Deutsche Balaton AG for a year in order to find a solution for the settlement
Earnings Scheduled For November 17, 2021
November 17, 4:59 AM
Companies Reporting Before The Bell
• ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion.
Biofrontera Bioscience Sponsored Study Titled ‘Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp’ Posted To ClinicalTrials.Gov
September 29, 8:37 AM
https://clinicaltrials.gov/ct2/show/NCT05060237
Biofrontera To Sell Photodynamic Therapy For Skin Diseases In Poland Via Supply Pact With Medac
July 23, 7:37 AM
Biofrontera Pharma GmbH, a wholly owned subsidiary of Biofrontera AG (NASDAQ:BFRA) and Medac Gesellschaft für klinische Spezialpräparate mbH have signed an exclusive license…
Biofrontera Sees June 2021 Revs €2.626M Vs €1.75M YoY
July 6, 10:12 AM
Biofrontera AG (NASDAQ:BFRA, Frankfurt Stock Exchange: B8F)))) (the "Company"), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of June 2021.
The
Biofrontera Stock Moves Higher On Outlining Clinical Update
June 22, 12:36 PM
Biofrontera AG (NASDAQ:BFRA) has provided an update on two submissions to the FDA, enabling the simultaneous use of up to three…
Uncategorized
Earnings Scheduled For May 11, 2021
May 11, 4:13 AM
Companies Reporting Before The Bell
• Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.